Intracranial metastases: Therapeutic options

Annals of Oncology

Volumn 14, Issue SUPPL. 3, 2003, Pages

  Westphal, M ^a   Heese, O ^a   de Wit, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHORIONIC GONADOTROPIN; CISPLATIN; CORTICOSTEROID; COTRIMOXAZOLE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; GADOLINIUM; HISTAMINE H2 RECEPTOR ANTAGONIST; METHOTREXATE; OMEPRAZOLE; PHENYTOIN; PREDNISONE; PROTON PUMP INHIBITOR; TEMOZOLOMIDE; TENIPOSIDE; TUMOR MARKER;

ADULT; ARTICLE; BEHAVIOR DISORDER; BLEEDING; BRAIN BIOPSY; BRAIN CANCER; BRAIN METASTASIS; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; HEADACHE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; LABORATORY TEST; LUNG SMALL CELL CANCER; MENINGEAL METASTASIS; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEIZURE; SPEECH DISORDER; SYMPTOM; TESTIS CANCER;

EID: 0038298065     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg741     Document Type: Article

References (27)

1. Fidler IJ, Yano S, Zhang RD et al. The seed soil hypothesis: vascularisation and brain metastasis. Lancet Oncol 2002; 3: 53-57.
2. Posner JB. Management of brain metastases. Rev Neurol 1992; 148: 477-487.
3. Delattre JY, Krol G, Thaler HT et al. Distribution of brain metastases. Arch Neurol 1988; 45: 741-744.
4. Patchell RA, Tibbs PA, Walsch JW et al. A randomized trial of surgery in the treatment of single metastasis to the brain. N Engl J Med 1990; 322: 494-500.
5. Berk L. An overview of radiotherapy trials for the treatment of brain metastases. Oncology 1995; 9: 1205-1212.
6. Sneed PK, Lamborn KR, Forstner JM et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999; 43: 549-558.
7. Glantz MJ, Cole BF, Forsyth PA et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 1886-1893.
8. Byrne TN, Cascino TL, Posner JB. Brain metastasis from melanoma. J Neurooncol 1983; 1: 313-317.
9. Posner JB. Neurologic complications of cancer. Philadelphia, PA: FA Davis 1995.
10. Batchelor T, deAngelis LM. Medical management of cerebral metastases. Neurosurg Clin North Am 1996; 7: 435-446.
11. Vecht CJ, Hovestadt A, Verbiest HBC et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8 and 16 milligrams per day. Neurology 1994; 44: 675-680.
12. Werk EE, Choi Y, Sholiton Z et al. Interference in the effect of dexamethasone by diphenylhydantoin. N Engl J Med 1969; 281: 32-34.
13. Lesser GJ. Chemotherapy of cerebral metastases from solid tumors. Neurosurg Clin North Am 1996; 7: 527-536.
14. Postmus PE, Haaxma-Reiche H, Smit EF et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain irradiation therapy. A phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 2000; 18: 3400-3408.
15. Franciosi V, Cocconi G, Michiara M et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, non-small cell lung cancer or malignant melanoma: a prospective study. Cancer 1999; 85: 1599-1605.
16. Dardoufas C, Miladoe A, Skarleas C et al. Concomitant temozolamide (TMZ) and radiotherapy (RT) followed by adjuvant treatment with temozolamide in patients with brain metastases from solid tumors. Proc Am Soc Clin Oncol 2001; 20: 75b (Abstr 2048).
17. Antonadou D, Paraskevaides M, Sarris G et al. Temozolamide enhances radiation treatment efficacy in brain metastases: a randomized phase II study. J Clin Oncol 2002; 20: 3644-3650.
18. Rosner D, Nemoto T, Lane WW. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 1986; 58: 832-839.
19. Boogerd W, Dalesio O, Bais EM et al. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992; 69: 972-980.
20. Kaba SE, Kyritsis AP, Hess K et al. TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors. J Clin Oncol 1997; 15: 1063-1070.
21. Zulkowski K, Kath R, Semrau R et al. Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine. J Cancer Res Clin Oncol 2002; 128: 111-113.
22. Fossa SD, Bokemeyer C, Gerl A et al. Treatment outcome in patients with brain metastases from malignant germ cell tumors. Cancer 1999; 85: 988-997.
23. Orlando L, Curigliano G, Colleoni M et al. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer. Anticancer Res 2002; 22: 3057-3059.
24. Lutterbach J, Bartelt S, Ostertag C. Long-term survival in patients with brain metastases. J Cancer Res Clin Oncol 2002; 128: 417-425.
25. Wronski M, Arbit E. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000; 93: 9-18.
26. Sneed PK, Suh JH, Goetsch SJ et al. A multi-institutional review of radiosurgery alone vs. radiosurgery vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastasis. Int J Radiat Oncol 2002; 53: 519-526.
27. Regine WF, Huhn JL, Patchell RA et al. Risk of symptomatic brain tumor recurrence and neurologich deficit after radiosurgery alone in patients with newly diagnosed brain metastasis: results and implications. Int J Radiat Oncol 2002; 52: 333-338.